In silico approach: biological prediction of nordentatin derivatives as anticancer agent inhibitors in the cAMP pathway.
RSC Adv
; 10(70): 42733-42743, 2020 Nov 23.
Article
en En
| MEDLINE
| ID: mdl-35514899
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
RSC Adv
Año:
2020
Tipo del documento:
Article